Beyond Air, Inc. Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31)
Beyond Air, Inc. (XAIR) reported Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) of $2.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-30.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss · last filed 2018-03-30
- Beyond Air, Inc. available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2017-12-31 was -$3.00K.
- Beyond Air, Inc. available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2017 was $2.00K.
| Period end | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 12 month |
|---|---|---|---|
| 2017-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $2.00K 10-K · filed 2018-03-30 | |
| 2017-09-30 | $5.00K 10-Q · filed 2017-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |